Tennessee 2025-2026 Regular Session

Tennessee Senate Bill SB0463 Compare Versions

OldNewDifferences
11
2-HOUSE BILL 595
3- By Hemmer
2+<BillNo> <Sponsor>
43
54 SENATE BILL 463
65 By Briggs
76
87
98 SB0463
109 002107
1110 - 1 -
1211
1312 AN ACT to amend Tennessee Code Annotated, Title 56
1413 and Title 71, relative to families.
1514
1615 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:
1716 SECTION 1. This act is known and may be cited as the "Freedom to Grow Our
1817 Tennessee Families Act."
1918 SECTION 2. Tennessee Code Annotated, Title 56, Chapter 7, Part 23, is amended by
2019 adding the following as a new section:
2120 (a) As used in this section:
2221 (1) "Enrollee" means a person on whose behalf a health insurer is
2322 obligated to pay benefits or provide services under a health benefit plan;
2423 (2) "Experimental fertility procedure" means a procedure for which the
2524 published medical evidence is not sufficient for the American Society for
2625 Reproductive Medicine, its successor organization, or a comparable organization
2726 to regard the procedure as established medical practice;
2827 (3) "Fertility diagnostic care" means procedures, products, medications,
2928 and services intended to provide information and counseling about an individual's
3029 fertility, including laboratory assessments and imaging studies;
3130 (4) "Fertility patient" means:
3231 (A) An individual or couple with infertility;
3332 (B) An individual unable to conceive as an individual or with a
3433 partner because the individual or couple does not have the necessary
3534 gametes for conception; or
3635
3736
3837 - 2 - 002107
3938
4039 (C) A couple that is at increased risk of transmitting a serious
4140 inheritable genetic or chromosomal condition to a child;
4241 (5) "Fertility preservation services":
4342 (A) Means procedures, products, medications, and services
4443 intended to preserve fertility, consistent with established medical practice
4544 and professional guidelines published by the American Society for
4645 Reproductive Medicine, its successor organization, or a comparable
4746 organization, for an individual who has a medical condition or who is
4847 expected to receive medical treatment that may cause or has the
4948 potential to cause a risk of impairment of fertility; and
5049 (B) Includes evaluation expenses; laboratory assessments;
5150 medications; treatment associated with fertility preservation services; the
5251 procurement and cryopreservation of gametes, embryos, and
5352 reproductive material; and storage from the time of cryopreservation for a
5453 period of at least three (3) years;
5554 (6) "Fertility treatment" means procedures, products, medications, and
5655 services intended to achieve pregnancy that results in a live birth with healthy
5756 outcomes and that are provided in a manner consistent with established medical
5857 practice and professional guidelines published by the American Society for
5958 Reproductive Medicine, its successor organization, or a comparable
6059 organization;
6160 (7) "Gamete" means sperm or eggs;
6261 (8) "Health benefit plan" means a contract or policy for health insurance
6362 coverage, as defined in § 56-7-109;
6463
6564
6665 - 3 - 002107
6766
6867 (9) "Health insurer" means a health insurance entity, as defined in § 56-
6968 7-109; and
7069 (10) "Infertility" means:
7170 (A) The inability to establish pregnancy or to carry a pregnancy to
7271 live birth after twelve (12) months of regular, unprotected sexual
7372 intercourse when the couple has the necessary gametes for conception,
7473 or a period of less than twelve (12) months due to a person's age or other
7574 factors when the couple has the necessary gametes for conception. A
7675 pregnancy that does not result in a live birth does not toll or restart the
7776 twelve-month period of time described in this subdivision (a)(7)(A); or
7877 (B) The presence of a condition recognized by a licensed
7978 physician that impacts an individual's ability to establish pregnancy or to
8079 carry a pregnancy based on a patient's medical, sexual, and reproductive
8180 history, age, physical findings, or diagnostic testing, or any combination of
8281 such factors.
8382 (b) A health insurer that issues, delivers, amends, or renews a health benefit
8483 plan that is to be in effect in this state on or after January 1, 2026, shall provide
8584 coverage for all of the following:
8685 (1) Fertility diagnostic care;
8786 (2) Fertility treatment; and
8887 (3) Fertility preservation services.
8988 (c) Coverage required by subsection (b) must:
9089 (1) Include at least three (3) complete oocyte retrievals with unlimited
9190 embryo transfers from those oocyte retrievals or from any oocyte retrieval
9291 performed prior to January 1, 2026, in accordance with the guidelines of the
9392
9493
9594 - 4 - 002107
9695
9796 American Society for Reproductive Medicine, using single embryo transfer when
9897 recommended and medically appropriate; and
9998 (2) Be provided regardless of whether donor gametes or embryos are
10099 used or an embryo is transferred to the uterus of a person acting as surrogate.
101100 (d) Coverage for fertility preservation services pursuant to subsection (b) must
102101 be provided regardless of an enrollee's past or present treatment for cancer, sickle cell
103102 disease, lupus, menorrhagia, endometriosis, or uterine fibroids.
104103 (e) Relative to coverage required by subsection (b), a health insurer shall not:
105104 (1) Impose a waiting period;
106105 (2) Use a prior diagnosis or prior fertility treatment as a basis for
107106 excluding, limiting, or otherwise restricting the availability of such coverage;
108107 (3) Impose limitations on coverage for fertility services based on an
109108 enrollee's use of donor gametes, donor embryos, or surrogacy; or
110109 (4) Impose different limitations on coverage for, provide different benefits
111110 to, or impose different requirements on a class of persons on account of an
112111 individual's actual or perceived race, color, sex, disability, ancestry, or
113112 relationship status.
114113 (f) Any limitation a health insurer imposes on the coverage required by this
115114 section must be based on an enrollee's medical history and clinical guidelines adopted
116115 by the health insurer. Any clinical guidelines used by a health insurer must be based on
117116 current guidelines developed by the American Society for Reproductive Medicine, its
118117 successor organization, or a comparable organization; must cite with specificity any data
119118 or scientific reference relied upon; must be maintained in written form; and must be
120119 made available to an enrollee in writing upon request.
121120 (g) This section does not require a health insurer to provide coverage for:
122121
123122
124123 - 5 - 002107
125124
126125 (1) An experimental fertility procedure; or
127126 (2) Nonmedical costs related to donor gametes, donor embryos, or
128127 surrogacy.
129128 (h) The commissioner of commerce and insurance is authorized to promulgate
130129 rules to effectuate this section, including, but not limited to, cost-sharing, benefit design,
131130 and clinical guidelines. When promulgating such rules, the commissioner shall consider
132131 the clinical guidelines developed by the American Society for Reproductive Medicine, its
133132 successor organization, or a comparable organization. The rules must be promulgated
134133 in accordance with the Uniform Administrative Procedures Act, compiled in title 4,
135134 chapter 5.
136135 SECTION 3. Tennessee Code Annotated, Section 71-3-104(b)(1), is amended by
137136 deleting the subsection and substituting the following:
138137 (1) A caretaker relative who becomes ineligible for any reason is eligible for
139138 transitional childcare assistance for a period of not less than six (6) months. The
140139 department shall pay childcare assistance on a sliding fee scale based upon a family's
141140 income for so long as federal funding or any related waiver is in effect.
142141 SECTION 4. Tennessee Code Annotated, Section 71-5-107(a), is amended by adding
143142 the following as a new subsection:
144143 (29) Fertility care for a fertility patient, as described in SECTION 2.
145144 SECTION 5. This act takes effect January 1, 2026, the public welfare requiring it.